Laser-guided bladder cancer removal
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests a new imaging method that helps surgeons see bladder cancer clearly during surgery, so they can remove it precisely. It may help ensure all cancer is removed and reduce the chance of leaving any behind.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have a suspected or confirmed bladder tumor and are scheduled for a partial bladder removal surgery.
- You are willing to provide written consent and follow the study plan.
- You do not have any other invasive cancer or severe health conditions like recent heart attack or stroke.
- You are not pregnant or breastfeeding, and you do not have severe blood in your urine or allergies to drugs or food.
- You do not have urinary tract infections or structural issues, and you have not joined another experimental trial in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy and immunotherapy to treat large, non-invasive bladder cancer before and after surgery. It aims to avoid removing the bladder while still effectively treating the cancer.
This trial tests a special imaging dye that lights up bladder cancer during surgery, helping doctors see and remove it more precisely. It may help ensure all cancer is removed while sparing healthy tissue.
This trial is testing whether artificial intelligence (AI) can help surgeons perform a more precise removal of bladder tumors during a procedure called TURBT. It is for people with early-stage bladder cancer that hasn't spread into the muscle layer.
This trial uses advanced MRI scanning to guide treatment decisions for muscle invasive bladder cancer. It aims to improve outcomes by personalizing therapy based on detailed imaging.
This trial studies a bladder-sparing treatment plan that uses MRI to guide therapy for muscle-invasive bladder cancer. It combines maximal tumor removal, chemotherapy, and radiation to avoid bladder removal.
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
Hear when a new NMIBC trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.